News
ESSA Pharma Board of Directors Approves Stock Option Plan RSU Plan and Option Grants
ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress
ESSA to Present at Ladenburg Thalmann Healthcare Conference
ESSA Pharma to Present at H.C. Wainwright 21st Annual Global Investment Conference
ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Process of US$36 Million
ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement
ESSA Pharma Provides Corporate Update and Reports Financial Results for the Fiscal Third Quarter Ended June 20, 2019
ESSA Announces that the Scheme of Arrangement with Realm Therapeutics has become Effective
ESSA Announces Court Sanction of the Scheme of Arrangement with Realm Therapeutics
ESSA Expands Leadership Team by Appointing Alessandra Cesano as Chief Medical Officer